Contrast-Enhanced Mammography-Guided Breast Biopsy: Single-Center Experience.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 36722757.
- Also identified by DOI 10.2214/AJR.22.28780.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This prospective single-center study enrolled 50 women with 51 contrast-enhanced mammography (CEM)-enhancing lesions that lacked a sonographic or mammographic correlate. Trial participants underwent CEM-guided biopsy. Biopsy was technically successful for 46 lesions and was not performed for five nonvisualized lesions (all nonmass enhancement), yielding a cancellation rate of 9.8%. Mean biopsy time was 16.6 minutes. All biopsies revealed concordant pathology (25 benign, 10 high-risk, 11 malignant). No non-visualized or benign lesion yielded malignancy at follow-up.
Medical subject headings
- Breast
- Breast Neoplasms